These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

344 related items for PubMed ID: 16154196

  • 1. A phase II randomized double-masked trial of pegaptanib, an anti-vascular endothelial growth factor aptamer, for diabetic macular edema.
    Cunningham ET, Adamis AP, Altaweel M, Aiello LP, Bressler NM, D'Amico DJ, Goldbaum M, Guyer DR, Katz B, Patel M, Schwartz SD, Macugen Diabetic Retinopathy Study Group.
    Ophthalmology; 2005 Oct; 112(10):1747-57. PubMed ID: 16154196
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals.
    Adamis AP, Altaweel M, Bressler NM, Cunningham ET, Davis MD, Goldbaum M, Gonzales C, Guyer DR, Barrett K, Patel M, Macugen Diabetic Retinopathy Study Group.
    Ophthalmology; 2006 Jan; 113(1):23-8. PubMed ID: 16343627
    [Abstract] [Full Text] [Related]

  • 5. Pegaptanib sodium for macular edema secondary to branch retinal vein occlusion.
    Wroblewski JJ, Wells JA, Gonzales CR.
    Am J Ophthalmol; 2010 Jan; 149(1):147-54. PubMed ID: 19875087
    [Abstract] [Full Text] [Related]

  • 6. Pegaptanib sodium for macular edema secondary to central retinal vein occlusion.
    Wroblewski JJ, Wells JA, Adamis AP, Buggage RR, Cunningham ET, Goldbaum M, Guyer DR, Katz B, Altaweel MM, Pegaptanib in Central Retinal Vein Occlusion Study Group.
    Arch Ophthalmol; 2009 Apr; 127(4):374-80. PubMed ID: 19365011
    [Abstract] [Full Text] [Related]

  • 7. Pegaptanib for neovascular age-related macular degeneration.
    Gragoudas ES, Adamis AP, Cunningham ET, Feinsod M, Guyer DR, VEGF Inhibition Study in Ocular Neovascularization Clinical Trial Group.
    N Engl J Med; 2004 Dec 30; 351(27):2805-16. PubMed ID: 15625332
    [Abstract] [Full Text] [Related]

  • 8. Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
    Nguyen QD, Brown DM, Marcus DM, Boyer DS, Patel S, Feiner L, Gibson A, Sy J, Rundle AC, Hopkins JJ, Rubio RG, Ehrlich JS, RISE and RIDE Research Group.
    Ophthalmology; 2012 Apr 30; 119(4):789-801. PubMed ID: 22330964
    [Abstract] [Full Text] [Related]

  • 9. Intravitreal bevacizumab (Avastin) therapy for persistent diffuse diabetic macular edema.
    Haritoglou C, Kook D, Neubauer A, Wolf A, Priglinger S, Strauss R, Gandorfer A, Ulbig M, Kampik A.
    Retina; 2006 Apr 30; 26(9):999-1005. PubMed ID: 17151486
    [Abstract] [Full Text] [Related]

  • 10. Long-term effect of intravitreal bevacizumab (avastin) in patients with chronic diffuse diabetic macular edema.
    Kook D, Wolf A, Kreutzer T, Neubauer A, Strauss R, Ulbig M, Kampik A, Haritoglou C.
    Retina; 2008 Oct 30; 28(8):1053-60. PubMed ID: 18779710
    [Abstract] [Full Text] [Related]

  • 11. Intravitreal aflibercept for diabetic macular edema.
    Korobelnik JF, Do DV, Schmidt-Erfurth U, Boyer DS, Holz FG, Heier JS, Midena E, Kaiser PK, Terasaki H, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Zeitz O, Metzig C, Brown DM.
    Ophthalmology; 2014 Nov 30; 121(11):2247-54. PubMed ID: 25012934
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3.
    Rajendram R, Fraser-Bell S, Kaines A, Michaelides M, Hamilton RD, Esposti SD, Peto T, Egan C, Bunce C, Leslie RD, Hykin PG.
    Arch Ophthalmol; 2012 Aug 30; 130(8):972-9. PubMed ID: 22491395
    [Abstract] [Full Text] [Related]

  • 14. Randomized trial of intravitreal bevacizumab alone or combined with triamcinolone versus macular photocoagulation in diabetic macular edema.
    Soheilian M, Ramezani A, Obudi A, Bijanzadeh B, Salehipour M, Yaseri M, Ahmadieh H, Dehghan MH, Azarmina M, Moradian S, Peyman GA.
    Ophthalmology; 2009 Jun 30; 116(6):1142-50. PubMed ID: 19376585
    [Abstract] [Full Text] [Related]

  • 15. Year 2 efficacy results of 2 randomized controlled clinical trials of pegaptanib for neovascular age-related macular degeneration.
    VEGF Inhibition Study in Ocular Neovascularization (V.I.S.I.O.N.) Clinical Trial GroupCentre for Vision Sciences, The Queen's University of Belfast and The Royal Victoria Hospital, Belfast, United Kingdom., Chakravarthy U, Adamis AP, Cunningham ET, Goldbaum M, Guyer DR, Katz B, Patel M.
    Ophthalmology; 2006 Sep 30; 113(9):1508.e1-25. PubMed ID: 16828500
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema.
    Do DV, Nguyen QD, Boyer D, Schmidt-Erfurth U, Brown DM, Vitti R, Berliner AJ, Gao B, Zeitz O, Ruckert R, Schmelter T, Sandbrink R, Heier JS, da Vinci Study Group.
    Ophthalmology; 2012 Aug 30; 119(8):1658-65. PubMed ID: 22537617
    [Abstract] [Full Text] [Related]

  • 18. Long-term outcomes of ranibizumab therapy for diabetic macular edema: the 36-month results from two phase III trials: RISE and RIDE.
    Brown DM, Nguyen QD, Marcus DM, Boyer DS, Patel S, Feiner L, Schlottmann PG, Rundle AC, Zhang J, Rubio RG, Adamis AP, Ehrlich JS, Hopkins JJ, RIDE and RISE Research Group.
    Ophthalmology; 2013 Oct 30; 120(10):2013-22. PubMed ID: 23706949
    [Abstract] [Full Text] [Related]

  • 19. Intravitreal Aflibercept Injection in Diabetic Macular Edema Patients with and without Prior Anti-Vascular Endothelial Growth Factor Treatment: Outcomes from the Phase 3 Program.
    Do DV, Nguyen QD, Vitti R, Berliner AJ, Gibson A, Saroj N, Soo Y, Boyer DS.
    Ophthalmology; 2016 Apr 30; 123(4):850-7. PubMed ID: 26832658
    [Abstract] [Full Text] [Related]

  • 20. Intravitreal Aflibercept for Diabetic Macular Edema: 100-Week Results From the VISTA and VIVID Studies.
    Brown DM, Schmidt-Erfurth U, Do DV, Holz FG, Boyer DS, Midena E, Heier JS, Terasaki H, Kaiser PK, Marcus DM, Nguyen QD, Jaffe GJ, Slakter JS, Simader C, Soo Y, Schmelter T, Yancopoulos GD, Stahl N, Vitti R, Berliner AJ, Zeitz O, Metzig C, Korobelnik JF.
    Ophthalmology; 2015 Oct 30; 122(10):2044-52. PubMed ID: 26198808
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.